Influence of preoperative anti‐cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the <scp>J</scp>apanese <scp>S</scp>ociety of <scp>H</scp>epato‐<scp>B</scp>iliary‐<scp>P</scp>ancreatic <scp>S</scp>urgery

Abstract

Neoadjuvant therapy may not increase the mortality and morbidity rate and may be able to increase the chance for curative resection against resectable tumor.